TIS tissue therapies limited

referral to ema, page-2

  1. 2,243 Posts.
    lightbulb Created with Sketch. 109
    Well, on my rough and ready calcs, they could survive on about $200,000 per month if they stop massive spends on consultants and trials etc.

    They have $5 million in cash, so it looks like we should be ok for a while.

    Would love to know what the "other expenditure" of $135,890 is comprised of. Boston cant be cheap, I guess.

    You would have thought SM might have made an announcement comforting shareholders about our cash position in light of the recent debacle...

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.